tiprankstipranks

Raymond Debbane Insider Profile

11 Followers
Raymond Debbane, Director at Lexicon Pharmaceuticals, holds 6.79M shares in Lexicon Pharmaceuticals (Ticker: LXRX), holds 134.39K shares in WW International (Ticker: WW), holds 0.00 shares in Blue Buffalo (Ticker: BUFF). Most recently, Raymond Debbane Bought ― shares of Lexicon Pharmaceuticals on Oct 12, 2023 for an estimated value of 1.10M.
tipranks
Raymond Debbane

Raymond Debbane
Lexicon Pharmaceuticals (LXRX)
Director

Ranked #12,398 out of 97,825 Corporate Insiders

Profitable Transactions

50%
3 out of 6 Profitable Transactions

Average Return

+24.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$18M
98.31%
1.69%
A breakdown of Raymond Debbane's holdings

Insider Roles

Lexicon Pharmaceuticals
(LXRX)
Director
WW International
(WW)
Former Director
Roles that Raymond Debbane holds in companies

Most Profitable Insider Trade

Stock:
Lexicon Pharmaceuticals
(LXRX)
Rating:Informative Buy
Date:Oct 12, 2023 - Today
Return:+150.00%
The most profitable trade made by Raymond Debbane

Raymond Debbane's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Lexicon Pharmaceuticals
Oct 12, 2023
Director
Informative Buy
1.10M
$17.66M
BUFF
Blue Buffalo
Apr 24, 2018
Uninformative Sell
$0.00
WW International
May 11, 2023
Former Director
Uninformative Buy
$303.71K
~CERE
Ceres Inc
Feb 08, 2012
Uninformative Buy
$6.62K
List of latest transactions for each holding click on a transaction to see Raymond Debbane's performance on stock

Raymond Debbane insider profile FAQ

What is the percentage of profitable transactions made by Raymond Debbane?
The percentage of profitable transactions made by Raymond Debbane is 50%.
    What is the average return per transaction made by Raymond Debbane?
    The average return per transaction made by Raymond Debbane is 24.20%.
      What stocks does Raymond Debbane hold?
      Raymond Debbane holds: LXRX, BUFF, WW, ~CERE stocks.
        What was Raymond Debbane’s latest transaction?
        Raymond Debbane latest transaction was an Informative Buy of $1.10M.
          What was Raymond Debbane's most profitable transaction?
          Raymond Debbane’s most profitable transaction was an Informative Buy of LXRX stock on October 12, 2023. The return on the trade was 150.00%.
            What is Raymond Debbane's role in Lexicon Pharmaceuticals?
            Raymond Debbane's role in Lexicon Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.